SCHEMBL24577285

SCHEMBL24577285

COCCn1cc(-c2cn3ncc(C(=O)Nc4cc(NC(=O)CCl)cnc4C)c3s2)cn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKE Q14164 6/20 0.42
▸ TBK1 Q9UHD2 6/20 0.42
▸ MAP3K7 O43318 2/20 0.35
▸ JAK1 P23458 3/20 0.34
▸ TYK2 P29597 3/20 0.34
▸ JAK3 P52333 3/20 0.34
▸ JAK2 O60674 3/20 0.34
▸ KAT5 Q92993 1/20 0.34
▸ USP30 Q70CQ3 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ PDGFRA P16234 1/20 0.33
▸ HRH3 Q9Y5N1 1/20 0.33
▸ BACE1 P56817 1/20 0.33
▸ HDAC1 Q13547 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29759532 1.00 IKBKE (0.42) IKBKETBK1MAP3K7JAK1TYK2
SCHEMBL24577629 0.94 IKBKE (0.41) IKBKETBK1MAP3K7JAK1TYK2
SCHEMBL29759547 0.94 IKBKE (0.41) IKBKETBK1MAP3K7JAK1TYK2
SCHEMBL24577406 0.93 IKBKE (0.36) IKBKETBK1CHRM1PDGFRAHRH3
SCHEMBL29759874 0.93 IKBKE (0.40) IKBKETBK1MAP3K7JAK1TYK2
SCHEMBL24577220 0.93 IKBKE (0.40) IKBKETBK1MAP3K7JAK1TYK2
SCHEMBL29759890 0.93 IKBKE (0.38) IKBKETBK1JAK1TYK2JAK3
SCHEMBL24577482 0.91 IKBKE (0.43) IKBKETBK1JAK1TYK2JAK3
SCHEMBL24578953 0.90 IKBKE (0.44) IKBKETBK1JAK1TYK2JAK3
SCHEMBL24578724 0.89 IKBKE (0.39) IKBKETBK1JAK1TYK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022136509-A1 PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2022-06-30 — — WO disclosed
Send feedback